| Year |
Citation |
Score |
| 2020 |
Gattaz WF, Saracco-Alvarez R, Daltio CS, Van de Bilt MT, Ortegón JJ, Villaseñor-Bayardo SJ, Louzã M, Elkis H, Soares B, Cabrera Jaramillo P, Lawson F, Díaz-Galvis L. Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability. Neuropsychiatric Disease and Treatment. 16: 2063-2072. PMID 32982245 DOI: 10.2147/Ndt.S233537 |
0.379 |
|
| 2020 |
Valiengo L, Serpa M, Elkis H, Bilt Mvd, Lacerda A, Gattaz W, Brunoni A. S193. Efficacy And Safety Of Transcranial Direct Current Stimulation For Treating Negative Symptoms In Schizophrenia: The Follow-Up Phase Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.259 |
0.318 |
|
| 2019 |
Valiengo LDCL, Goerigk S, Gordon PC, Padberg F, Serpa MH, Koebe S, Santos LAD, Lovera RAM, Carvalho JB, van de Bilt M, Lacerda ALT, Elkis H, Gattaz WF, Brunoni AR. Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry. PMID 31617873 DOI: 10.1001/Jamapsychiatry.2019.3199 |
0.311 |
|
| 2019 |
Joaquim HPG, Costa AC, Serpa MH, Talib LL, Gattaz WF. Reduced Annexin A3 in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. PMID 31372726 DOI: 10.1007/S00406-019-01048-3 |
0.412 |
|
| 2019 |
Valiengo L, Gordon PC, de Carvalho JB, Rios RM, Koebe S, Serpa MH, van de Bilt M, Lacerda A, Elkis H, Gattaz WF, Brunoni AR. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. Trends in Psychiatry and Psychotherapy. PMID 31241683 DOI: 10.1590/2237-6089-2018-0047 |
0.372 |
|
| 2019 |
Setti VPC, Loch AA, Modelli A, de Almeida Rocca CC, Hungerbuehler I, van de Bilt MT, Gattaz WF, Rössler W. Disclosing the diagnosis of schizophrenia: A pilot study of the 'Coming Out Proud' intervention. The International Journal of Social Psychiatry. 20764019840057. PMID 30915887 DOI: 10.1177/0020764019840057 |
0.331 |
|
| 2018 |
Joaquim HPG, Costa AC, Gattaz WF, Talib LL. Kynurenine is correlated with IL-1β in plasma of schizophrenia patients. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29306989 DOI: 10.1007/S00702-018-1838-8 |
0.337 |
|
| 2018 |
Valiengo L, Gordon P, Serpa M, Lacerda A, Gattaz W, Bilt MVd, Helkis H, Brunoni A. T51. Treatment Of Negative Symptoms Of Schizophrenia With Transcranial Current Stimulation (Tdcs): Results Of Randomized, Double-Blinded, Sham-Controlled Trial Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.327 |
0.322 |
|
| 2018 |
Valiengo L, Bilt MTvd, Serpa M, Gordon P, Helkis H, Gattaz WF, Lacerda A, Brunoni A. T204. Treatment of Negative Symptoms of Schizophrenia With tDCS (Transcranial Direct Current Stimulation): A Randomized, Sham-Controlled, Double-Blinded Clinical Trial Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.541 |
0.317 |
|
| 2017 |
Joaquim HPG, Zanetti MV, Serpa MH, Van de Bilt MT, Sallet PC, Chaim TM, Busatto GF, Gattaz WF, Talib LL. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis. Schizophrenia Research. PMID 28888361 DOI: 10.1016/J.Schres.2017.08.062 |
0.373 |
|
| 2017 |
Serpa MH, Doshi J, Erus G, Chaim-Avancini TM, Cavallet M, van de Bilt MT, Sallet PC, Gattaz WF, Davatzikos C, Busatto GF, Zanetti MV. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis. Psychological Medicine. 1-15. PMID 28826419 DOI: 10.1017/S0033291717001015 |
0.329 |
|
| 2017 |
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Thibaut F, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care. International Journal of Psychiatry in Clinical Practice. 1-9. PMID 28498090 DOI: 10.1080/13651501.2017.1291839 |
0.356 |
|
| 2017 |
Bevilacqua Guarniero F, Bellinghini RH, Gattaz WF. The schizophrenia stigma and mass media: a search for news published by wide circulation media in Brazil. International Review of Psychiatry (Abingdon, England). 1-7. PMID 28492091 DOI: 10.1080/09540261.2017.1285976 |
0.366 |
|
| 2017 |
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Gattaz WF, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73 |
0.324 |
|
| 2016 |
Schmitt A, Martins-de-Souza D, Akbarian S, Cassoli JS, Ehrenreich H, Fischer A, Fonteh A, Gattaz WF, Gawlik M, Gerlach M, Grünblatt E, Halene T, Hasan A, Hashimoto K, Kim YK, et al. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-27. PMID 27782767 DOI: 10.1080/15622975.2016.1224929 |
0.588 |
|
| 2016 |
Torres US, Duran FL, Schaufelberger MS, Crippa JA, Louzã MR, Sallet PC, Kanegusuku CY, Elkis H, Gattaz WF, Bassitt DP, Zuardi AW, Hallak JE, Leite CC, Castro CC, Santos AC, et al. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness. Neuroimage. Clinical. 12: 1-15. PMID 27354958 DOI: 10.1016/J.Nicl.2016.06.002 |
0.38 |
|
| 2015 |
Mury FB, da Silva WC, Barbosa NR, Mendes CT, Bonini JS, Sarkis JE, Cammarota M, Izquierdo I, Gattaz WF, Dias-Neto E. Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. PMID 26661385 DOI: 10.1007/S00406-015-0665-2 |
0.68 |
|
| 2015 |
Vendramini PH, Gattaz WF, Schmitt A, Falkai P, Eberlin MN, Martins-de-Souza D. Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia. Schizophrenia Research. PMID 26545296 DOI: 10.1016/J.Schres.2015.10.019 |
0.779 |
|
| 2015 |
van de Bilt MT, Prado CM, Ojopi EP, Sousa RT, Loch AA, Zanetti MV, Talib LL, Gattaz WF. Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment. Schizophrenia Research. 168: 587-8. PMID 26298540 DOI: 10.1016/J.Schres.2015.08.002 |
0.379 |
|
| 2015 |
Talib LL, Hototian SR, Joaquim HP, Forlenza OV, Gattaz WF. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients. European Archives of Psychiatry and Clinical Neuroscience. PMID 25920742 DOI: 10.1007/S00406-015-0600-6 |
0.306 |
|
| 2015 |
Gama MA, Raposo NR, Mury FB, Lopes FC, Dias-Neto E, Talib LL, Gattaz WF. Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25913570 DOI: 10.1007/S00702-015-1401-9 |
0.692 |
|
| 2015 |
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Thibaut F, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 16: 142-70. PMID 25822804 DOI: 10.3109/15622975.2015.1009163 |
0.358 |
|
| 2015 |
Ferreira AS, Raposo NR, Sallet PC, Van de Bilt MT, Machado-Vieira R, Talib LL, Gattaz WF. Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. European Archives of Psychiatry and Clinical Neuroscience. 265: 167-70. PMID 24831601 DOI: 10.1007/S00406-014-0505-9 |
0.324 |
|
| 2014 |
Forlenza OV, Coutinho AM, Aprahamian I, Prando S, Mendes LL, Diniz BS, Gattaz WF, Buchpiguel CA. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. Acs Chemical Neuroscience. 5: 484-9. PMID 24730717 DOI: 10.1021/Cn5000315 |
0.321 |
|
| 2014 |
Gattaz WF, Campos JA, Lacerda AL, Henna E, Ruschel SI, Bressan RA, de Oliveira IR, Rocha FL, Grabowski HM, Sacomani E, Louzã MR, Quevedo J, Elkis H, Zorzetto Filho D, Périco Cde A, et al. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Current Medical Research and Opinion. 30: 695-709. PMID 24289141 DOI: 10.1185/03007995.2013.869201 |
0.305 |
|
| 2014 |
Café-Mendes CC, Gattaz WF, Schmitt A, Britto LRG, Martins-de-Souza D. Proteomic characterization of the brain and cerebrospinal fluid of schizophrenia patients Proteomics and Metabolomics in Psychiatry. 29: 1-15. DOI: 10.1159/000358021 |
0.557 |
|
| 2014 |
Talib LL, Joaquim H, Serpa M, Busatto G, Bilt MVd, Zanetti M, Gattaz W. Poster #M23 ANTIPSYCHOTIC TREATMENT DECREASED IPLA2 ACTIVITY IN FIRST EPISODE DRUG NAÏVE PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70573-0 |
0.366 |
|
| 2013 |
Kerr DS, Talib LL, Yamamoto VJ, Ferreira AS, Zanetti MV, Serpa MH, Busatto GF, Van de Bilt MT, Gattaz WF. Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia. Schizophrenia Research. 147: 203-4. PMID 23587695 DOI: 10.1016/J.Schres.2013.03.026 |
0.352 |
|
| 2013 |
Loch AA, Guarniero FB, Lawson FL, Hengartner MP, Rössler W, Gattaz WF, Wang YP. Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil. Bmc Psychiatry. 13: 92. PMID 23517184 DOI: 10.1186/1471-244X-13-92 |
0.366 |
|
| 2013 |
Loch AA, Hengartner MP, Guarniero FB, Lawson FL, Wang YP, Gattaz WF, Rössler W. The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared. Psychiatry Research. 205: 185-91. PMID 23266022 DOI: 10.1016/J.Psychres.2012.11.023 |
0.334 |
|
| 2013 |
Radanovic M, Sousa RT, Valiengo L, Gattaz WF, Forlenza OV. Formal Thought Disorder and language impairment in schizophrenia. Arquivos De Neuro-Psiquiatria. 71: 55-60. PMID 23249974 DOI: 10.1590/S0004-282X2012005000015 |
0.377 |
|
| 2013 |
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 2-44. PMID 23216388 DOI: 10.3109/15622975.2012.739708 |
0.352 |
|
| 2013 |
Schaeffer EL, Kühn F, Schmitt A, Gattaz WF, Gruber O, Schneider-Axmann T, Falkai P, Schmitt A. Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 187-95. PMID 22806004 DOI: 10.1007/S00702-012-0859-Y |
0.326 |
|
| 2012 |
de Sousa RT, Busnello JV, Forlenza OV, Zanetti MV, Soeiro-de-Souza MG, van de Bilt MT, Moreno RA, Zarate CA, Gattaz WF, Machado-Vieira R. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. Journal of Psychiatric Research. 46: 1564-8. PMID 23000368 DOI: 10.1016/J.Jpsychires.2012.08.011 |
0.313 |
|
| 2012 |
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 318-78. PMID 22834451 DOI: 10.3109/15622975.2012.696143 |
0.356 |
|
| 2012 |
Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate CA, Machado-Vieira R. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatrica Scandinavica. 126: 332-41. PMID 22676371 DOI: 10.1111/J.1600-0447.2012.01889.X |
0.319 |
|
| 2012 |
Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF. Does lithium prevent Alzheimer's disease? Drugs & Aging. 29: 335-42. PMID 22500970 DOI: 10.2165/11599180-000000000-00000 |
0.322 |
|
| 2012 |
Soeiro-de-Souza MG, Post RM, de Sousa ML, Missio G, do Prado CM, Gattaz WF, Moreno RA, Machado-Vieira R. Does BDNF genotype influence creative output in bipolar I manic patients? Journal of Affective Disorders. 139: 181-6. PMID 22484201 DOI: 10.1016/J.Jad.2012.01.036 |
0.318 |
|
| 2012 |
Massuda R, Chaves C, Trzesniak C, Machado-de-Sousa JP, Zanetti MV, Murray RM, Gattaz WF, Busatto GF. Meeting report: the Schizophrenia International Research Society (SIRS) South America Conference (August 5-7, 2011). Schizophrenia Research. 137: 1-6. PMID 22459672 DOI: 10.1016/J.Schres.2012.03.013 |
0.328 |
|
| 2012 |
Valiengo LL, Soeiro-de-Souza MG, Marques AH, Moreno DH, Juruena MF, Andreazza AC, Gattaz WF, Machado-Vieira R. Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. Journal of Affective Disorders. 138: 149-52. PMID 22305430 DOI: 10.1016/J.Jad.2011.11.046 |
0.302 |
|
| 2012 |
Soeiro-de-Souza MG, Bio DS, David DP, Rodrigues dos Santos D, Kerr DS, Gattaz WF, Machado-Vieira R, Moreno RA. COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. Journal of Affective Disorders. 136: 370-6. PMID 22222175 DOI: 10.1016/J.Jad.2011.11.021 |
0.31 |
|
| 2012 |
Dias-Neto E, Gattaz WF. About the art of being a scientist and eating jabuticabas - A tribute to Prof. Dr. Ricardo Renzo Brentani | Da arte de fazer ciência e de comer jabuticabas - uma homenagem ao Prof. Dr. Ricardo Renzo Brentani Revista De Psiquiatria Clinica. 39: 1-4. DOI: 10.1590/S0101-60832012000100001 |
0.649 |
|
| 2012 |
Martins-de-Souza D, Maccarrone G, Schmitt A, Falkai P, Dias-Neto E, Gattaz WF, Turck CW. PROTEOME ANALYSES OF POST-MORTEM BRAIN TISSUE FROM PATIENTS WITH SCHIZOPHRENIA SUGGEST DYSFUNCTION OF OLIGODENDROCYTES AND ASTROCYTES AND POTENTIAL BIOMARKER CANDIDATES? Schizophrenia Research. 136: S61. DOI: 10.1016/S0920-9964(12)70231-1 |
0.802 |
|
| 2012 |
Talib L, Hototian S, Forlenza O, Gattaz W. Cholinesterase inhibitors increase iPLA2 activity in platelets of patients with Alzheimer's disease Alzheimers & Dementia. 8: 113. DOI: 10.1016/J.Jalz.2012.05.291 |
0.321 |
|
| 2012 |
Kerr D, Santos Bd, Dias-Neto E, Gattaz W. APOE-ε4 interaction with single-nucleotide polymorphisms and risk for Alzheimer's disease Alzheimers & Dementia. 8: 666. DOI: 10.1016/J.Jalz.2012.05.1798 |
0.664 |
|
| 2011 |
Gattaz WF, Valente KD, Raposo NR, Vincentiis S, Talib LL. Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis. Journal of Psychiatric Research. 45: 1617-20. PMID 21813137 DOI: 10.1016/J.Jpsychires.2011.07.005 |
0.38 |
|
| 2011 |
Eckert GP, Schaeffer EL, Schmitt A, Maras A, Gattaz WF. Increased brain membrane fluidity in schizophrenia. Pharmacopsychiatry. 44: 161-2. PMID 21710408 DOI: 10.1055/S-0031-1279731 |
0.349 |
|
| 2011 |
Schaeffer EL, De-Paula VJ, da Silva ER, de A Novaes B, Skaf HD, Forlenza OV, Gattaz WF. Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1273-9. PMID 21387172 DOI: 10.1007/S00702-011-0619-4 |
0.307 |
|
| 2011 |
Bio DS, Gattaz WF. Vocational rehabilitation improves cognition and negative symptoms in schizophrenia. Schizophrenia Research. 126: 265-9. PMID 20800453 DOI: 10.1016/J.Schres.2010.08.003 |
0.32 |
|
| 2011 |
Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HP, Diniz BS, Gattaz WF. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. Journal of Psychiatric Research. 45: 220-4. PMID 20576277 DOI: 10.1016/J.Jpsychires.2010.06.002 |
0.313 |
|
| 2011 |
de Figueiredo Rocha S, Dias-Neto E, Gattaz WF. Music performance anxiety: Translation, adaptation and validation of the kenny music performance anxiety inventory (K-MPAI) to the Portuguese language | Ansiedade na performance musical: Tradução, adaptação e validação do kenny music performance anxiety inventory (K-MPAI) para a língua Portuguesa Revista De Psiquiatria Clinica. 38: 217-221. DOI: 10.1590/S0101-60832011000600001 |
0.648 |
|
| 2011 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN, Souza GH, Marangoni S, Novello JC, Turck CW, Dias-Neto E. Erratum to Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia [Journal of Psychiatric Research (2009); 43(11): 978–86] Journal of Psychiatric Research. 45: 283. DOI: 10.1016/J.Jpsychires.2010.06.003 |
0.783 |
|
| 2011 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Falkai P, Bahn S, Dias-Neto E, Turck CW. What Does Proteomics Tell Us About Schizophrenia Schizophrenia Bulletin. 37: 116-117. DOI: 10.1007/978-94-007-0837-2_16 |
0.812 |
|
| 2010 |
Scorza FA, Schmitt A, Cysneiros RM, Arida RM, Cavalheiro EA, Gattaz WF. Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia. Clinics (Sã£O Paulo, Brazil). 65: 539-46. PMID 20535373 DOI: 10.1590/S1807-59322010000500012 |
0.391 |
|
| 2010 |
Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Izzo G, Gattaz WF. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 774-80. PMID 20491609 DOI: 10.3109/15622971003797241 |
0.302 |
|
| 2010 |
Santos PE, Thomaz CE, dos Santos D, Freire R, Sato JR, Louzã M, Sallet P, Busatto G, Gattaz WF. Exploring the knowledge contained in neuroimages: statistical discriminant analysis and automatic segmentation of the most significant changes. Artificial Intelligence in Medicine. 49: 105-15. PMID 20452195 DOI: 10.1016/J.Artmed.2010.03.003 |
0.344 |
|
| 2010 |
Martins-De-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G, Turck CW, Gattaz WF. Proteome analysis of schizophrenia brain tissue. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 110-20. PMID 20109112 DOI: 10.3109/15622970903490626 |
0.801 |
|
| 2010 |
Dias-Neto E, Martins-De-Souza D, Ojopi EPB, Gattaz WF. Genetic and proteomic studies in Schizophrenia Advances in Schizophrenia Research 2009. 193-218. DOI: 10.1007/978-1-4419-0913-8_10 |
0.751 |
|
| 2009 |
Scorza FA, Cysneiros RM, Terra VC, Scorza CA, Cavalheiro EA, Ribeiro MO, Gattaz WF. Omega-3 consumption and sudden cardiac death in schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 81: 241-5. PMID 19628381 DOI: 10.1016/J.Plefa.2009.06.008 |
0.342 |
|
| 2009 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E. Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation. Bmc Psychiatry. 9: 17. PMID 19405953 DOI: 10.1186/1471-244X-9-17 |
0.801 |
|
| 2009 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 259: 151-63. PMID 19165527 DOI: 10.1007/S00406-008-0847-2 |
0.804 |
|
| 2009 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Maccarrone G, Hunyadi-Gulyás E, Eberlin MN, Souza GH, Marangoni S, Novello JC, Turck CW, Dias-Neto E. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. Journal of Psychiatric Research. 43: 978-86. PMID 19110265 DOI: 10.1016/J.Jpsychires.2008.11.006 |
0.809 |
|
| 2009 |
Gregório SP, Sallet PC, Do KA, Lin E, Gattaz WF, Dias-Neto E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Research. 165: 1-9. PMID 19054571 DOI: 10.1016/J.Psychres.2007.08.011 |
0.732 |
|
| 2009 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarrone G, Turck CW, Dias-Neto E. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 275-89. PMID 19034380 DOI: 10.1007/S00702-008-0156-Y |
0.794 |
|
| 2009 |
Mendes CT, Mury FB, de Sá Moreira E, Alberto FL, Forlenza OV, Dias-Neto E, Gattaz WF. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. European Archives of Psychiatry and Clinical Neuroscience. 259: 16-22. PMID 18932008 DOI: 10.1007/S00406-008-0828-5 |
0.692 |
|
| 2009 |
Schmitt A, Steyskal C, Bernstein HG, Schneider-Axmann T, Parlapani E, Schaeffer EL, Gattaz WF, Bogerts B, Schmitz C, Falkai P. Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathologica. 117: 395-407. PMID 18777029 DOI: 10.1007/S00401-008-0430-Y |
0.394 |
|
| 2009 |
Guimarães PE, Fridman C, Gregório SP, Kalil EM, Cristante AF, Teixeira WG, Rodrigues CJ, Costa MC, Gattaz WF, Barros TE, Oliveira PS, Dias-Neto E. DNA polymorphisms as tools for spinal cord injury research. Spinal Cord. 47: 171-5. PMID 18504448 DOI: 10.1038/Sc.2008.67 |
0.664 |
|
| 2008 |
Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, Turck CW. Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. Journal of Separation Science. 31: 3122-6. PMID 18693323 DOI: 10.1002/Jssc.200800224 |
0.78 |
|
| 2008 |
Scorza FA, Cysneiros RM, Cavalheiro EA, Arida RM, Gattaz WF. Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel? Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 30: 169-70. PMID 18592110 DOI: 10.1590/S1516-44462008000200017 |
0.323 |
|
| 2008 |
Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ, Okasha A, Singh B, Stein DJ, Olie JP, Fleischhacker WW, Moeller HJ. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia Schizophrenia Research. 100: 20-38. PMID 18243663 DOI: 10.1016/J.Schres.2007.11.033 |
0.364 |
|
| 2008 |
Mury FB, Barbosa NR, Defillipo PP, Mendes CT, Gattaz WF, Dias-Neto E. P3-340: PLA2 enzyme: New target for memantine action Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1909 |
0.653 |
|
| 2008 |
Forlenza OV, Mendes CT, Mury FB, Nunes PV, Dias-Neto E, Gattaz WF. P2-391: Lithium inhibits GSK3β transcription in hippocampal neurons and human leukocytes Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1469 |
0.656 |
|
| 2008 |
Mury FB, Barbosa NR, Defillipo PP, Mendes CT, Gattaz WF, Dias-Neto E. Memantine induces expression of PLA2 genes in rat brain: Possible implications for reverse learning and memory of Alzheimer's disease patients European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.631 |
0.69 |
|
| 2007 |
Barbosa NR, Junqueira RM, Vallada HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 257: 340-3. PMID 17629734 DOI: 10.1007/S00406-007-0736-0 |
0.377 |
|
| 2007 |
Martins-de-Souza D, Martins D, Menezes de Oliveira B, dos Santos Farias A, Horiuchi RS, Crepaldi Domingues C, de Paula E, Marangoni S, Gattaz WF, Dias-Neto E, Camillo Novello J. The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Briefings in Functional Genomics & Proteomics. 6: 70-5. PMID 17556486 DOI: 10.1093/Bfgp/Elp007 |
0.733 |
|
| 2007 |
Forlenza OV, Schaeffer EL, Gattaz WF. The role of phospholipase A2 in neuronal homeostasis and memory formation: Implications for the pathogenesis of Alzheimer's disease Journal of Neural Transmission. 114: 231-238. PMID 17131232 DOI: 10.1007/S00702-006-0597-0 |
0.306 |
|
| 2006 |
Passos Gregorio S, Gattaz WF, Tavares H, Kieling C, Timm S, Wang AG, Berg Rasmussen H, Werge T, Dias-Neto E. Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects. Schizophrenia Research. 88: 275-82. PMID 16899352 DOI: 10.1016/J.Schres.2006.06.036 |
0.73 |
|
| 2006 |
Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, Abraham R, Gattaz WF, Vaz AJ, Dias-Neto E. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. European Archives of Psychiatry and Clinical Neuroscience. 256: 307-10. PMID 16816897 DOI: 10.1007/S00406-006-0612-3 |
0.669 |
|
| 2006 |
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Long-term treatment of schizophrenia World Journal of Biological Psychiatry. 7: 5-40. PMID 16509050 DOI: 10.1080/15622970500483177 |
0.512 |
|
| 2006 |
Häfner H, Ehrenreich H, Gattaz WF, Louza MR, Riecher-Rössler A, Kulkarni J. Oestrogen-A protective factor in schizophrenia? Current Psychiatry Reviews. 2: 339-352. DOI: 10.2174/157340006778018120 |
0.359 |
|
| 2006 |
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 1: Acute treatment | Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia parte 1: Tratamento agudo Revista De Psiquiatria Clinica. 33: 7-64. |
0.474 |
|
| 2006 |
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 2: Long-term treatment | Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia parte 2: Tratamento de longo prazo Revista De Psiquiatria Clinica. 33: 65-100. |
0.47 |
|
| 2005 |
Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. The American Journal of Psychiatry. 162: 1879-87. PMID 16199834 DOI: 10.1176/Appi.Ajp.162.10.1879 |
0.323 |
|
| 2005 |
Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ, Altamura AC, Andreasen N, Barnes TRE, Beckmann H, Ciprian-Ollivier J, Crow T, David A, Davidson M, Deakin B, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: Acute treatment of schizophrenia World Journal of Biological Psychiatry. 6: 132-191. PMID 16173147 DOI: 10.1080/15622970510030090 |
0.572 |
|
| 2005 |
Abrahao AL, Focaccia R, Gattaz WF. Childhood meningitis increases the risk for adult schizophrenia World Journal of Biological Psychiatry. 6: 44-48. PMID 16166023 DOI: 10.1080/15622970510030063 |
0.303 |
|
| 2005 |
Gregório SP, Mury FB, Ojopi EB, Sallet PC, Moreno DH, Yacubian J, Tavares H, Santos FR, Gattaz WF, Dias-Neto E. Nogo CAA 3'UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder. Schizophrenia Research. 75: 5-9. PMID 15820318 DOI: 10.1016/J.Schres.2004.11.010 |
0.72 |
|
| 2005 |
Junqueira R, Cordeiro Q, Meira-Lima I, Gattaz WF, Vallada H. Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatric Genetics. 14: 157-60. PMID 15318030 DOI: 10.1097/00041444-200409000-00007 |
0.333 |
|
| 2004 |
Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Linde I, Maras A, Dittmann RW. Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial. Pharmacopsychiatry. 37: 279-285. PMID 15551194 DOI: 10.1055/S-2004-832684 |
0.331 |
|
| 2004 |
Basile LFH, Yacubian J, Castro CCd, Gattaz WF. Widespread electrical cortical dysfunction in schizophrenia Schizophrenia Research. 69: 255-266. PMID 15469197 DOI: 10.1016/J.Schres.2003.09.018 |
0.334 |
|
| 2004 |
Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, Braus DF, Gattaz WF. Altered thalamic membrane phospholipids in schizophrenia: a postmortem study Biological Psychiatry. 56: 41-45. PMID 15219471 DOI: 10.1016/J.Biopsych.2004.03.019 |
0.312 |
|
| 2004 |
Gattaz WF, Forlenza OV, Talib LL, Barbosa NR, Bottino CM. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 591-601. PMID 15088152 DOI: 10.1007/S00702-004-0142-Y |
0.311 |
|
| 2004 |
Louzã MR, Marques AP, Elkis H, Bassitt D, Diegoli M, Gattaz WF. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophrenia Research. 66: 97-100. PMID 15061241 DOI: 10.1016/S0920-9964(03)00082-3 |
0.332 |
|
| 2004 |
Yacubian J, Castro CC, Ometto M, Barbosa E, Camargo CP, Tavares H, Cerri GG, Gattaz WF. Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia Pharmacopsychiatry. 36: 275. DOI: 10.1055/S-2003-825570 |
0.354 |
|
| 2004 |
Eckert GP, Schaeffer E, Schmitt A, Maras A, Müller WE, Gattaz WF. P.4.11 Specific alterations of brain membranes in schizophrenia European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)90089-2 |
0.371 |
|
| 2003 |
Sallet PC, Elkis H, Alves TM, Oliveira JR, Sassi E, Castro CCd, Busatto GF, Gattaz WF. Reduced Cortical Folding in Schizophrenia: An MRI Morphometric Study American Journal of Psychiatry. 160: 1606-1613. PMID 12944334 DOI: 10.1176/Appi.Ajp.160.9.1606 |
0.4 |
|
| 2003 |
Sallet PC, Elkis H, Alves TM, Oliveira JR, Sassi E, Castro CCd, Busatto GF, Gattaz WF. Rightward cerebral asymmetry in subtypes of schizophrenia according to Leonhard's classification and to DSM-IV: a structural MRI study. Psychiatry Research-Neuroimaging. 123: 65-79. PMID 12738344 DOI: 10.1016/S0925-4927(03)00020-9 |
0.385 |
|
| 2003 |
Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophrenia Research. 61: 1-6. PMID 12648730 DOI: 10.1016/S0920-9964(02)00281-5 |
0.342 |
|
| 2002 |
Yacubian J, de Castro CC, Ometto M, Barbosa E, de Camargo CP, Tavares H, Cerri GG, Gattaz WF. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophrenia Research. 58: 117-22. PMID 12409151 DOI: 10.1016/S0920-9964(01)00394-2 |
0.387 |
|
| 2002 |
Beckmann H, Gattaz WF. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 931-8. PMID 12111479 DOI: 10.1007/S007020200076 |
0.456 |
|
| 2001 |
Frieboes RM, Moises HW, Gattaz WF, Yang L, Li T, Liu X, Vetter P, Macciardi F, Hwu HG, Henn F. Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. American Journal of Medical Genetics. 105: 246-9. PMID 11353443 DOI: 10.1002/Ajmg.1262 |
0.376 |
|
| 2000 |
Gattaz WF, Lara DR, Elkis H, Portela LV, Gonçalves CA, Tort AB, Henna J, Souza DO. Decreased S100-beta protein in schizophrenia: preliminary evidence. Schizophrenia Research. 43: 91-5. PMID 10858627 DOI: 10.1016/S0920-9964(99)00146-2 |
0.366 |
|
| 1998 |
Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, Maurer K, Munk-Jørgensen P, Nowotny B, Riecher-Rössler A, Stein A. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin. 24: 99-113. PMID 9502549 DOI: 10.1093/Oxfordjournals.Schbul.A033317 |
0.377 |
|
| 1996 |
Gattaz WF, Levy R, Cairns NJ, Förstl H, Braus DF, Maras A. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia]. Fortschritte Der Neurologie-Psychiatrie. 64: 8-12. PMID 8850090 DOI: 10.1055/S-2007-996367 |
0.325 |
|
| 1996 |
Gattaz WF, Cairns NJ, Levy R, Förstl H, Braus DF, Maras A. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. 246: 129-31. PMID 8739397 DOI: 10.1007/Bf02189113 |
0.335 |
|
| 1995 |
Brunner J, Gattaz WF. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 246: 13-16. PMID 8773214 DOI: 10.1007/Bf02191810 |
0.364 |
|
| 1995 |
Brunner J, Gattaz WF. Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats. Psychiatry Research-Neuroimaging. 58: 165-169. PMID 8570769 DOI: 10.1016/0165-1781(95)02717-B |
0.345 |
|
| 1995 |
Gattaz WF, Maras A, Cairns NJ, Levy R, Förstl H. Decreased phospholipase A2 activity in Alzheimer brains. Biological Psychiatry. 37: 13-7. PMID 7893853 DOI: 10.1016/0006-3223(94)00123-K |
0.329 |
|
| 1995 |
Gattaz WF, Schmitt A, Maras A. Increased platelet phospholipase A2 activity in schizophrenia Schizophrenia Research. 16: 1-6. PMID 7547640 DOI: 10.1016/0920-9964(94)00060-L |
0.385 |
|
| 1994 |
Dalgalarrondo P, Gattaz WF. Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment. European Archives of Psychiatry and Clinical Neuroscience. 244: 272-277. PMID 7893773 DOI: 10.1007/Bf02190380 |
0.305 |
|
| 1994 |
Häfner H, Maurer K, Löffler W, Fätkenheuer B, Heiden WAD, Riecher-Rössler A, Behrens S, Gattaz WF. The Epidemiology of Early Schizophrenia British Journal of Psychiatry. 164: 29-38. DOI: 10.1192/S0007125000292714 |
0.335 |
|
| 1992 |
Gattaz WF, Dalgalarrondo P, Schröder HC. Abnormalities in serum concentrations of interleukin-2, interferon-α and interferon-γ in schizophrenia not detected Schizophrenia Research. 6: 237-241. PMID 1571315 DOI: 10.1016/0920-9964(92)90006-Q |
0.304 |
|
| 1992 |
Gattaz WF, Behrens S, Vry JD, Häfner H. Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten―ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie Fortschritte Der Neurologie Psychiatrie. 60: 8-16. PMID 1312053 DOI: 10.1055/S-2007-999120 |
0.313 |
|
| 1992 |
Behrens S, Häfner H, DeVry J, Gattaz WF. Estradiol Attenuates Dopamine-Mediated Behavior In Rats: Implications For Sex Differences In Schizophrenia Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00940 |
0.33 |
|
| 1992 |
Vogel P, Soddu G, Riecher A, Gattaz WF. Effects of the Menstrual Cycle on the Therapeutic Response in Schizophrenia Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00472 |
0.36 |
|
| 1992 |
Gattaz WF, Steudle A, Pangerl A. Accelerated Breakdown of Platelet Membrane Phospholipids in Schizophrenia Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00463 |
0.33 |
|
| 1992 |
Pangerl AM, Ferber E, Gattaz WF. Increased Platelet Phospholipase A2 Activity in schizophrenia Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00041 |
0.332 |
|
| 1992 |
Dalgalarrondo P, Schröder HC, Gattaz WF. Serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia: Failure to detect abnormalities Schizophrenia Research. 6: 140. DOI: 10.1016/0920-9964(92)90202-G |
0.304 |
|
| 1992 |
Gattaz WF, Ferber E, Pangerl A. Increased phospholipase A2 activity in schizophrenia Schizophrenia Research. 6: 135. DOI: 10.1016/0920-9964(92)90191-7 |
0.343 |
|
| 1992 |
Steudle A, Pangerl AM, Miller BE, Gattaz WF. Effects of neuroleptic therapy on phospholipid metabolism in schizophrenia Schizophrenia Research. 6: 118. DOI: 10.1016/0920-9964(92)90156-Y |
0.348 |
|
| 1992 |
Behrens S, Häfner H, DeVry J, Gattaz WF. Estradiol attenuates dopamine-mediated behavior in rats. Implications for sex differences in schizophrenia Schizophrenia Research. 6: 114. DOI: 10.1016/0920-9964(92)90145-U |
0.33 |
|
| 1991 |
Angst J, Mortensen PB, Munk-Jørgensen P, Strömgren E, Häfner H, Gattaz WF, Murray RM, Gupta S, Der G. Is schizophrenia disappearing? - Introductory remarks of the chief-editor European Archives of Psychiatry and Clinical Neuroscience. 240: 373-378. PMID 1831671 DOI: 10.1007/Bf02279770 |
0.373 |
|
| 1991 |
Häfner H, Behrens S, Vry JD, Gattaz WF. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Research-Neuroimaging. 38: 125-134. PMID 1754627 DOI: 10.1016/0165-1781(91)90038-Q |
0.338 |
|
| 1991 |
Pangerl AM, Steudle A, Jaroni HW, Rüfer R, Gattaz WF. Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biological Psychiatry. 30: 837-840. PMID 1751626 DOI: 10.1016/0006-3223(91)90239-I |
0.352 |
|
| 1991 |
Häfner H, Behrens S, Vry JD, Gattaz WF. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. European Archives of Psychiatry and Clinical Neuroscience. 241: 65-68. PMID 1653619 DOI: 10.1007/Bf02193758 |
0.301 |
|
| 1989 |
Gattaz WF, Rost W, Hübner CvK, Bauer K. Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics. Biological Psychiatry. 25: 247-255. PMID 2643996 DOI: 10.1016/0006-3223(89)90172-8 |
0.308 |
|
| 1989 |
Nemeroff CB, Bissette G, Widerlov E, Beckmann H, Gerner R, Manberg PJ, Lindstrom L, Prange AJ, Gattaz WF. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences. 1: 16-20. PMID 2577718 DOI: 10.1176/Jnp.1.1.16 |
0.495 |
|
| 1988 |
Hübner CVK, Gattaz WF. Tomografia cerebral computadorizada e esquizofrenia: revisão crítica da literatura Arquivos De Neuro-Psiquiatria. 46: 320-329. DOI: 10.1590/S0004-282X1988000300015 |
0.377 |
|
| 1987 |
Gattaz WF, Köllisch M, Thuren T, Virtanen JA, Kinnunen PKJ. Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy Biological Psychiatry. 22: 421-426. PMID 3567258 DOI: 10.1016/0006-3223(87)90164-8 |
0.33 |
|
| 1986 |
Gattaz WF, Roberts E, Beckmann H. Cerebrospinal fluid concentrations of free GABA in schizophrenia: no changes after haloperidol treatment. Journal of Neural Transmission. 66: 69-73. PMID 3734777 DOI: 10.1007/Bf01262959 |
0.446 |
|
| 1986 |
Gattaz WF, Köllisch M. Bromocriptine in the treatment of neuroleptic-resistant schizophrenia Biological Psychiatry. 21: 519-521. PMID 3697439 DOI: 10.1016/0006-3223(86)90193-9 |
0.332 |
|
| 1986 |
Rissler K, Cramer H, Schaudt D, Strubel D, Gattaz WF. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease. Neuroscience Research. 3: 213-225. PMID 2871533 DOI: 10.1016/0168-0102(86)90003-9 |
0.303 |
|
| 1986 |
Gattaz WF, Rissler K, Gattaz D, Cramer H. Effects of haloperidol on somatostatin-like immuno-reactivity in the CSF of schizophrenic patients Psychiatry Research-Neuroimaging. 17: 1-6. PMID 2868477 DOI: 10.1016/0165-1781(86)90035-1 |
0.302 |
|
| 1985 |
Beckmann H, Lang RE, Gattaz WF. Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. Psychoneuroendocrinology. 10: 187-91. PMID 4034849 DOI: 10.1016/0306-4530(85)90056-3 |
0.526 |
|
| 1985 |
Gattaz WF, Hannak D, Beckmann H. Increased CSF cortisol levels after neuroleptic treatment in schizophrenia. Psychoneuroendocrinology. 10: 351-4. PMID 2865767 DOI: 10.1016/0306-4530(85)90012-5 |
0.56 |
|
| 1985 |
Gattaz WF, Gasser T, Beckmann H. Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls. Biological Psychiatry. 20: 360-6. PMID 2858227 DOI: 10.1016/0006-3223(85)90038-1 |
0.456 |
|
| 1984 |
Gattaz WF, Cramer H, Beckmann H. Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. Biological Psychiatry. 19: 1229-35. PMID 6149769 |
0.511 |
|
| 1984 |
Beckmann H, Saavedra JM, Gattaz WF. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. Biological Psychiatry. 19: 679-84. PMID 6145452 |
0.489 |
|
| 1984 |
Beckmann H, Wetterberg L, Gattaz WF. Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry Research. 11: 107-10. PMID 6143334 DOI: 10.1016/0165-1781(84)90093-3 |
0.562 |
|
| 1983 |
Gattaz WF, Riederer P, Reynolds GP, Gattaz D, Beckmann H. Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients. Psychiatry Research. 8: 243-50. PMID 6576391 DOI: 10.1016/0165-1781(83)90012-4 |
0.521 |
|
| 1983 |
Beckmann H, Waldmeier P, Lauber J, Gattaz WF. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment. Journal of Neural Transmission. 57: 103-10. PMID 6194254 DOI: 10.1007/Bf01250052 |
0.53 |
|
| 1983 |
Gattaz WF, Kattermann R, Gattaz D, Beckmann H. Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP. Biological Psychiatry. 18: 935-9. PMID 6137251 |
0.44 |
|
| 1983 |
Gattaz WF, Cramer H, Beckmann H. Low CSF concentrations of cyclic GMP in schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 142: 288-91. PMID 6134562 DOI: 10.1192/Bjp.142.3.288 |
0.572 |
|
| 1983 |
Beckmann H, Reynolds GP, Sandler M, Waldmeier P, Lauber J, Riederer P, Gattaz WF. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 232: 463-71. PMID 6134517 DOI: 10.1007/Bf00344060 |
0.587 |
|
| 1982 |
Gattaz WF, Beckmann H. [The histocompatibility system in schizophrenia]. Arquivos De Neuro-Psiquiatria. 40: 223-9. PMID 6984326 DOI: 10.1590/S0004-282X1982000300002 |
0.571 |
|
| 1982 |
Gattaz WF, Waldmeier P, Beckmann H. CSF monoamine metabolites in schizophrenic patients. Acta Psychiatrica Scandinavica. 66: 350-60. PMID 6184954 |
0.474 |
|
| 1982 |
Gattaz WF, Gattaz D, Beckmann H. Glutamate in schizophrenics and healthy controls. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 231: 221-5. PMID 6123303 DOI: 10.1007/Bf00343292 |
0.52 |
|
| 1981 |
Gattaz WF, Kasper S, Kohlmeyer K, Beckmann H. [Cranial computed tomography in schizophrenia research]. Fortschritte Der Neurologie-Psychiatrie. 49: 286-91. PMID 7343465 DOI: 10.1055/s-2007-1002336 |
0.485 |
|
| 1981 |
Gattaz WF, Kasper S, Propping P, Friedl W, Beckmann H. Low platelet MAO activity and schizophrenia: sex differences. Acta Psychiatrica Scandinavica. 64: 167-74. PMID 7315498 DOI: 10.1111/j.1600-0447.1981.tb00771.x |
0.51 |
|
| 1981 |
Gattaz WF, Beckmann H. Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals. Acta Psychiatrica Scandinavica. 63: 479-85. PMID 7315490 DOI: 10.1111/j.1600-0447.1981.tb00697.x |
0.446 |
|
| 1981 |
Gattaz WF, Beckmann H. [HLA-system in psychiatric research (author's transl)]. Fortschritte Der Neurologie-Psychiatrie. 49: 145-51. PMID 7239401 DOI: 10.1055/s-2007-1002318 |
0.41 |
|
| 1981 |
Gattaz WF, Kasper S, Ewald R, Beckmann H. [HLA, schizophrenias and arthropathies]. Psychiatria Clinica. 14: 49-55. PMID 6973776 |
0.513 |
|
| 1981 |
Gattaz WF, Beckmann H, Mendlewicz J. HLA antigens and schizophrenia: a pool of two studies. Psychiatry Research. 5: 123-8. PMID 6945607 DOI: 10.1016/0165-1781(81)90042-1 |
0.548 |
|
| 1981 |
Mitterauer B, Lange V, Diebold K, Kick H, Schmidt G, Gattaz WF, Kasper S, Ewald R, Beckmann H, Olbrich D, Bojanovsky J. Nachruf auf Professor H. Mitsuda Psychopathology. 14: 66-66. DOI: 10.1159/000283902 |
0.44 |
|
| 1981 |
Gattaz WF, Kasper S, Ewald R, Beckmann H. HLA, Schizophrenien und Arthropathien Psychopathology. 14: 49-55. DOI: 10.1159/000283900 |
0.5 |
|
| 1980 |
Gattaz WF, Ewald RW, Beckmann H. The HLA system and schizophrenia. A study in a German population. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 228: 205-11. PMID 7416935 DOI: 10.1007/Bf00342346 |
0.552 |
|
| 1980 |
Gattaz WF, Kasper S, Beckmann H. HL-A-antigens, schizophrenia and brain atrophy. The British Journal of Psychiatry : the Journal of Mental Science. 137: 398-9. PMID 7192588 |
0.526 |
|
| 1980 |
Gattaz WF, Beckmann H. HLA antigens and schizophrenia. Lancet. 1: 98-9. PMID 6101450 DOI: 10.1016/S0140-6736(80)90526-7 |
0.501 |
|
| 1980 |
Gattaz WF, Kasper S, Beckmann H. HLA-Antigens, Schizophrenia and Brain Atrophy British Journal of Psychiatry. 137: 398-399. DOI: 10.1192/S000712500007210X |
0.571 |
|
| Show low-probability matches. |